4 completed, 1 recruiting. 5 Phase 1, 3 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 5 | Completed 4, Recruiting 1 |
| Phase 2 | 3 | Completed 2, Recruiting 1 |
Follow Hypophosphatasia: new trials by email Literature Review of Hypophosphatasia trials Research Report on Hypophosphatasia
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study to Assess Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of ALE1 in Healthy Adults and Adults With Hypophosphatasia in Order to Identify Suitable Doses of ALE1 ALE1, Placebo - Hypophosphatasia (HPP) | Phase 1 / Phase 2 | Recruiting | Alesta Therapeutics | 120 | 2025-09-30 | 2026-08-03 |
| Pilot Trial of Single Dose Ilofotase Alfa in Hypophosphatasia Ilofotase Alfa, 0.8 mg/kg, Ilofotase Alfa, 3.2 mg/kg - Hypophosphatasia | Phase 1 / Phase 2 | Completed | AM-Pharma | 12 | 2023-05-15 | 2025-02-27 |
| Study of ALXN1850 in Participants With Hypophosphatasia (HPP) ALXN1850 - Hypophosphatasia | Phase 1 | Completed | Alexion Pharmaceuticals, Inc. | 15 | 2021-09-28 | 2024-12-27 |
| Safety and Efficacy Study of Asfotase Alfa in Severely Affected Infants With Hypophosphatasia (HPP) asfotase alfa - Hypophosphatasia (HPP) | Phase 1 / Phase 2 | Completed | Alexion Pharmaceuticals, Inc. | 11 | 2008-09-01 | 2019-04-01 |
| Safety Study of Human Recombinant Tissue Non-Specific Alkaline Phosphatase Fusion Protein Asfotase Alfa in Adults With Hypophosphatasia (HPP) Asfotase Alfa - Hypophosphatasia (HPP) | Phase 1 | Completed | Alexion Pharmaceuticals, Inc. | 6 | 2008-08-01 | 2019-03-29 |
Bone Diseases (2) · Osteomalacia (2) · Rickets (2)
Congenital, Hereditary, and Neonatal Diseases and Abnormalities (5) · Genetic Diseases, Inborn (5) · Metabolic Diseases (5) · Metabolism, Inborn Errors (5) · Metal Metabolism, Inborn Errors (5) · Nutritional and Metabolic Diseases (5) · Avitaminosis (2) · Bone Diseases, Metabolic (2) · Calcium Metabolism Disorders (2) · Deficiency Diseases (2) · Malnutrition (2) · Musculoskeletal Diseases (2) · Nutrition Disorders (2) · Vitamin D Deficiency (2)
asfotase alfa (2)
Alexion Pharmaceuticals, Inc. (3) · AM-Pharma (1) · Alesta Therapeutics (1)
United States (3) · Canada (2) · Germany (2) · United Kingdom (2) · New Zealand (1) · United Arab Emirates (1)
PMID 22397652, PMID 26529632, PMID 32762706, PMID 39135540, PMID 41378916